Interleukin (IL)-35 Suppresses IL-6 and IL-8 Production in IL-17A-Stimulated Human Periodontal Ligament Cells

Overview

Journal Inflammation

Specialties Allergy & Immunology
Pathology

Date 2018 Nov 29

PMID 30484005

Citations 7

Authors

Satoru Shindo

Yoshitaka Hosokawa

Ikuko Hosokawa

Hideki Shiba

Affiliations

Soon will be listed here.

Abstract

Interleukin (IL)-35 is a novel anti-inflammatory cytokine that is produced by regulatory T cells. IL-35 is reported to suppress IL-17A-producing helper T (Th17) cell activation. IL-17A is related to progression of periodontitis. Furthermore, IL-35 and IL-17A are detected in human gingival crevicular fluid. However, the effect of IL-35 and interaction between IL-35 and IL-17A on pro-inflammatory cytokine production in human periodontal resident cells are still unclear. The aim of this study was to clarify the effect of IL-35 on IL-6 and IL-8 production in human periodontal ligament cells (HPDLCs) stimulated with IL-17A. IL-35 inhibited IL-6 and IL-8 production in IL-17A-stimulated HPDLCs. Moreover, western blot analysis showed that IL-35 suppressed extracellular signal-regulated kinase (ERK) and nuclear factor (NF)-κB p65 phosphorylation in IL-17A-stimulated HPDLCs. Our findings suggested that IL-35 produced from regulatory T cells might inhibit progression of periodontitis by decreasing IL-17A-induced levels of IL-6 and IL-8.

Citing Articles

Effect and mechanism of Sanqi () in treating periodontitis.

Yuanyuan A, Wang L, Yanjie L, Yanchun W, Xiaobin R, Hongbing H J Tradit Chin Med. 2025; 45(1):66-75.

PMID: 39957160 PMC: 11764944. DOI: 10.19852/j.cnki.jtcm.20241111.001.

IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions.

Shkundin A, Halaris A J Pers Med. 2024; 14(5).

PMID: 38793070 PMC: 11122344. DOI: 10.3390/jpm14050488.

IL-39 and IL-35 gingival crevicular fluid levels in diabetic patients with generalized periodontitis.

Hassan S, Abdelkawy M, Shaker O, Abdel Fattah Tarrad N Clin Oral Investig. 2024; 28(2):124.

PMID: 38286978 PMC: 10824872. DOI: 10.1007/s00784-023-05484-3.

Identification of microRNA-mRNA-TF regulatory networks in periodontitis by bioinformatics analysis.

Gao X, Zhao D, Han J, Zhang Z, Wang Z BMC Oral Health. 2022; 22(1):118.

PMID: 35397550 PMC: 8994180. DOI: 10.1186/s12903-022-02150-0.

Effect of nonsurgical periodontal therapy on gingival crevicular fluid levels of Interleukin-35 in patients with periodontitis.

Goswamy A, Hans M, Hans V, Sheokand V, Grover H J Oral Biol Craniofac Res. 2022; 12(2):268-272.

PMID: 35340815 PMC: 8943404. DOI: 10.1016/j.jobcr.2022.03.006.

References

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

Lin D, Li L, Sun Y, Wang W, Wang X, Ye Y . IL-17 regulates the expressions of RANKL and OPG in human periodontal ligament cells via TRAF6/TBK1-JNK/NF-κB pathways. Immunology. 2014; . PMC: 4557684. DOI: 10.1111/imm.12395. View

Olson B, Jankowska-Gan E, Becker J, Vignali D, Burlingham W, McNeel D . Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J Immunol. 2012; 189(12):5590-601. PMC: 3735346. DOI: 10.4049/jimmunol.1201744. View

Jung Y, Choi Y, An S, Lee H, Jun H, Choi B . Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. Mol Oral Microbiol. 2016; 32(4):301-313. DOI: 10.1111/omi.12172. View

Wilson N, Boniface K, Chan J, McKenzie B, Blumenschein W, Mattson J . Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007; 8(9):950-7. DOI: 10.1038/ni1497. View

Okada K, Fujimura T, Kikuchi T, Aino M, Kamiya Y, Izawa A . Effect of interleukin (IL)-35 on IL-17 expression and production by human CD4 T cells. PeerJ. 2017; 5:e2999. PMC: 5314955. DOI: 10.7717/peerj.2999. View

Shindo S, Hosokawa Y, Hosokawa I, Ozaki K, Matsuo T . Genipin inhibits IL-1β-induced CCL20 and IL-6 production from human periodontal ligament cells. Cell Physiol Biochem. 2014; 33(2):357-64. DOI: 10.1159/000356675. View

Fredriksson M, Bergstrom K, Asman B . IL-8 and TNF-alpha from peripheral neutrophils and acute-phase proteins in periodontitis. J Clin Periodontol. 2002; 29(2):123-8. DOI: 10.1034/j.1600-051x.2002.290206.x. View

Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S . IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999; 103(9):1345-52. PMC: 408356. DOI: 10.1172/JCI5703. View

10.

Takahashi K, Azuma T, Motohira H, Kinane D, Kitetsu S . The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol. 2005; 32(4):369-74. DOI: 10.1111/j.1600-051X.2005.00676.x. View

11.

Wu Y, Zhu L, Liu L, Zhang J, Peng B . Interleukin-17A stimulates migration of periodontal ligament fibroblasts via p38 MAPK/NF-κB -dependent MMP-1 expression. J Cell Physiol. 2013; 229(3):292-9. DOI: 10.1002/jcp.24444. View

12.

Cardoso C, Garlet G, Crippa G, Rosa A, Junior W, Rossi M . Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol. 2009; 24(1):1-6. DOI: 10.1111/j.1399-302X.2008.00463.x. View

13.

Wu S, Li Y, Li Y, Yao L, Lin T, Jiang S . Interleukin-35 attenuates collagen-induced arthritis through suppression of vascular endothelial growth factor and its receptors. Int Immunopharmacol. 2016; 34:71-77. DOI: 10.1016/j.intimp.2016.02.018. View

14.

Zhang X, Zhou Y, Zhang J, Zhou S, Wang M, Feng R . IL-35 inhibits acute graft-versus-host disease in a mouse model. Int Immunopharmacol. 2015; 29(2):383-392. DOI: 10.1016/j.intimp.2015.10.025. View

15.

Shen P, Roch T, Lampropoulou V, OConnor R, Stervbo U, Hilgenberg E . IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014; 507(7492):366-370. PMC: 4260166. DOI: 10.1038/nature12979. View

16.

Mitani A, Niedbala W, Fujimura T, Mogi M, Miyamae S, Higuchi N . Increased expression of interleukin (IL)-35 and IL-17, but not IL-27, in gingival tissues with chronic periodontitis. J Periodontol. 2014; 86(2):301-9. DOI: 10.1902/jop.2014.140293. View

17.

Wang Y, Mao Y, Zhang J, Shi G, Cheng L, Lin Y . IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells. J Cell Mol Med. 2017; 22(2):1014-1025. PMC: 5783847. DOI: 10.1111/jcmm.13428. View

18.

Sha X, Meng S, Li X, Xi H, Maddaloni M, Pascual D . Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway. J Biol Chem. 2015; 290(31):19307-18. PMC: 4521049. DOI: 10.1074/jbc.M115.663286. View

19.

Hashizume M, Hayakawa N, Mihara M . IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology (Oxford). 2008; 47(11):1635-40. DOI: 10.1093/rheumatology/ken363. View

20.

Devergne O, Birkenbach M, Kieff E . Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci U S A. 1997; 94(22):12041-6. PMC: 23696. DOI: 10.1073/pnas.94.22.12041. View